Sales decline 7.90% to Rs 1272.69 crore
Net Loss of Ranbaxy Laboratories reported to Rs 368.26 crore in the quarter ended September 2014 as against net loss of Rs 842.23 crore during the previous quarter ended September 2013. Sales declined 7.90% to Rs 1272.69 crore in the quarter ended September 2014 as against Rs 1381.84 crore during the previous quarter ended September 2013. ParticularsQuarter EndedSep. 2014Sep. 2013% Var.Sales1272.691381.84 -8 OPM %-12.23-7.37 -PBDT-272.48-168.60 -62 PBT-332.63-263.01 -26 NP-368.26-842.23 56Powered by Capital Market - Live News